Table 6.39Symptoms

Pain outcomeReferenceInterventionAssessment timeOutcome/effect size
Pain intensity at rest(VAS); pain intensity on activation (VAS); WOMAC pain1 RCT (Tascioglu et al. 2004) (N=60)Laser vs placebo laser3 weeks and 6 months follow-upNS
Pain (VAS); medical tenderness scoreRCT (Yurtkuran et al. 2007) (N=55)Laser acupuncture + exercise vs placebo laser acupuncture + exercise2 Weeks (end of treatment) and 12 weeks (10 weeks post-treatmentNS
Mixed (Knee or hand or thumb or unspecified sites)
Number of patients with no pain relief1 MA (Brosseau et al. 2006)1 RCT, N=8Laser vs placebo laserNot mentionedPeto OR 0.06,% CI 0.00 to 0.88, p=0.04
Favours laser
Patient pain – different scales1 MA (Brosseau et al. 2006)3 RCTs, N=145Laser vs placebo laserNot mentionedSignificant hetero geneity

From: 6, Non-pharmacological management of osteoarthritis

Cover of Osteoarthritis
Osteoarthritis: National Clinical Guideline for Care and Management in Adults.
NICE Clinical Guidelines, No. 59.
National Collaborating Centre for Chronic Conditions (UK).
Copyright © 2008, Royal College of Physicians of London.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.